For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Jubilant Biosys Logo

Your global leading partner in science for end to end CRDMO services

Author Archives: Jubilantbiosys

A proud moment for Jubilant Biosys !!

Our partner ‘Inipharm’ has announced the initiation of clinical trials with a compound that was discovered at our integrated drug discovery site, Bengaluru.

Posted in News |

POSH [Prevention of Sexual Harassment]

Posted in Policies |

Bio California (Global Partnering & investor conference)

Functional Area: Life Sciences

Posted in Events |

ACS Spring 2024

Functional Area: Life Sciences

Posted in Events |

DCAT Meeting

Functional Area: Life Sciences

Posted in Events |

CPHI Japan 2024

Functional Area: Life Sciences

Posted in Events |

Leveraging the Orbitrap HRMS for met-ID & large molecule analysis

Posted in In-House Insights New |

Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders

Authors: Sven Ruf, Sridharan Rajagopal, Sanjay Venkatachalapathi Kadnur, Mahanandeesha S. Hallur, Shilpa Rani, Rajendra Kristam, Srinivasan Swaminathan, Bharat Ravindra Zope, Pavan Kumar Gondrala, Indu Swamy, V. P. Rama Kishore Putta, Saravanan Kandan, Gernot Zech, Herman Schreuder, Christine Rudolph, Ralf Elvert, Joerg Czech, Swarnakumari Birudukota, M. Amir Siddiqui, Niranjan Naranapura Anand, Vishal Subhash Mane, Sreekanth Dittakavi, […]

Posted in Publications |

Annual Return

Annual Return FY-2021

Posted in Uncategorised |

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics.

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings.

Posted in Press Releases |